Fapon is a global leading life sciences company dedicated to providing integrated solutions and services for diagnostics, biopharma and biotherapy. Integrating a one-stop solution on raw materials, reagents and innovative open instrument platforms, the Company has grown into a leading supplier in in-vitro diagnostics. Fapon boasts advanced innovations in therapeutics technologies and AI algorithm platforms with data insights that contribute to a better and healthier world. Supported by its strong global R&D, manufacturing, sales and service network, Fapon's products have established presence in 68 countries and regions, serving more than 2,500 business partners worldwide.
| Website | https://en.faponbiotech.com/ |
| Revenue | $25 million |
| Employees | 182 (52 on RocketReach) |
| Founded | 2001 |
| Industry | Biotechnology Research |
Looking for a particular Fapon employee's phone or email?
The Fapon annual revenue was $25 million in 2026.
Paul Lundquist is the Chief Technology Officer, Sequencing of Fapon.
52 people are employed at Fapon.